Inhibition of nuclear factor-κB in the lungs prevents monocrotaline-induced pulmonary hypertension in mice
- PMID: 24614212
- DOI: 10.1161/HYPERTENSIONAHA.114.03220
Inhibition of nuclear factor-κB in the lungs prevents monocrotaline-induced pulmonary hypertension in mice
Abstract
Pulmonary arterial hypertension (PAH) is a devastating cardiopulmonary disorder with significant morbidity and mortality in patients with various lung and heart diseases. PAH is characterized by vascular obstruction which leads to a sustained increased pulmonary vascular resistance, vascular remodeling, and right ventricular hypertrophy and failure. Limited PAH therapies indicate that novel approaches are urgently needed for the treatment of PAH. Nuclear factor-κB (NF-κB) has been shown to play an important role in different cardiac pathologies; however, the role of NF-κB remains limited in the setting of PAH. Here, we investigated whether NF-κB inhibition in the lungs using Club (Clara) cell-10 promoter driving IκBα mutant had any effect in monocrotaline (MCT)-induced PAH mouse model. Our data revealed that MCT-induced PAH and right ventricular hypertrophy were associated with NF-κB activation, inflammatory response, and altered expression of bone morphogenetic protein receptor 2, inhibitor of differentiation, and Notch-3 signaling molecules in wild-type mice; and all these alterations were prevented in IκBα mutant mice treated with MCT. Moreover, endothelial cell apoptosis and endothelial-to-mesenchymal transition occurred in the lungs of MCT-treated wild-type mice and were restored in IκBα mutant+MCT mice, indicating an association with NF-κB signaling. In lung microvascular endothelial cells, IκBα (AA) mutant plasmid restored the decreased bone morphogenetic protein receptor 2 protein level and reversed the endothelial-to-mesenchymal transition process induced by transforming growth factor-β1. We conclude that NF-κB regulates bone morphogenetic protein receptor 2-inhibitor of differentiation-Notch-3 axis genes and the subsequent endothelial cell apoptosis and endothelial-to-mesenchymal transition events in the lungs, providing new mechanistic information about MCT-induced PAH and right ventricular hypertrophy.
Keywords: NF-kappa B; hypertension, pulmonary; mice.
Similar articles
-
NF-κB mediated miR-130a modulation in lung microvascular cell remodeling: Implication in pulmonary hypertension.Exp Cell Res. 2017 Oct 1;359(1):235-242. doi: 10.1016/j.yexcr.2017.07.024. Epub 2017 Jul 26. Exp Cell Res. 2017. PMID: 28755990
-
Activation of AMPK prevents monocrotaline-induced pulmonary arterial hypertension by suppression of NF-κB-mediated autophagy activation.Life Sci. 2018 Sep 1;208:87-95. doi: 10.1016/j.lfs.2018.07.018. Epub 2018 Jul 17. Life Sci. 2018. PMID: 30009823
-
Pyrrolidine dithiocarbamate restores endothelial cell membrane integrity and attenuates monocrotaline-induced pulmonary artery hypertension.Am J Physiol Lung Cell Mol Physiol. 2008 Jun;294(6):L1250-9. doi: 10.1152/ajplung.00069.2007. Epub 2008 Apr 4. Am J Physiol Lung Cell Mol Physiol. 2008. PMID: 18390833 Free PMC article.
-
BMP type II receptor as a therapeutic target in pulmonary arterial hypertension.Cell Mol Life Sci. 2017 Aug;74(16):2979-2995. doi: 10.1007/s00018-017-2510-4. Epub 2017 Apr 26. Cell Mol Life Sci. 2017. PMID: 28447104 Free PMC article. Review.
-
The transforming growth factor-β-bone morphogenetic protein type signalling pathway in pulmonary vascular homeostasis and disease.Exp Physiol. 2013 Aug;98(8):1262-6. doi: 10.1113/expphysiol.2012.069104. Epub 2013 May 3. Exp Physiol. 2013. PMID: 23645549 Review.
Cited by
-
Mesenchymal stromal cell-derived exosomes improve pulmonary hypertension through inhibition of pulmonary vascular remodeling.Respir Res. 2020 Mar 20;21(1):71. doi: 10.1186/s12931-020-1331-4. Respir Res. 2020. PMID: 32192495 Free PMC article.
-
Cigarette Smoke and Nicotine-Containing Electronic-Cigarette Vapor Downregulate Lung WWOX Expression, Which Is Associated with Increased Severity of Murine Acute Respiratory Distress Syndrome.Am J Respir Cell Mol Biol. 2021 Jan;64(1):89-99. doi: 10.1165/rcmb.2020-0145OC. Am J Respir Cell Mol Biol. 2021. PMID: 33058734 Free PMC article.
-
Pulmonary Hypertension and Right Ventricle: A Pathophysiological Insight.Clin Med Insights Cardiol. 2024 Sep 9;18:11795468241274744. doi: 10.1177/11795468241274744. eCollection 2024. Clin Med Insights Cardiol. 2024. PMID: 39257563 Free PMC article. Review.
-
Andrographolide Attenuates Established Pulmonary Hypertension via Rescue of Vascular Remodeling.Biomolecules. 2021 Nov 30;11(12):1801. doi: 10.3390/biom11121801. Biomolecules. 2021. PMID: 34944445 Free PMC article.
-
Notopterol Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rat.Front Cardiovasc Med. 2022 Jun 3;9:859422. doi: 10.3389/fcvm.2022.859422. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35722110 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous